Laboratory procurement governance

The institutional context

Research with peptide compounds within a UK institutional setting operates under layered governance — research ethics committees, MHRA clinical trial authorisations (where the work is a CTIMP), Home Office authorisation for animal research (ASPA 1986), HSE considerations for hazardous materials, biosafety oversight, material transfer agreements and institutional standard operating procedures. Procurement decisions sit within that framework, not outside it.

Categories of consideration

• Provenance and identity. Documented manufacturer or synthesiser identity, traceable batch records, COA referencing recognised analytical standards.
• Purity and characterisation. HPLC purity (typically ≥98% for biological assays), mass-spectrometry identity confirmation, residual solvent and endotoxin testing where the application requires it.
• Sterility and packaging. Appropriate to the intended use; injectable in-vivo work has different requirements from in-vitro receptor assays.
• Cold-chain integrity. Temperature-monitored shipping, validated handling on receipt, defined storage conditions.
• Regulatory provenance. Whether the compound is being supplied as a research-grade material, a regulator-approved investigational medicinal product, or otherwise — and whether the supply route is congruent with the intended research use.
• Institutional approvals. Documentation that the relevant research ethics committee, animal welfare body, biosafety committee and material transfer steps have approved the work and the material.

What this page deliberately does not include

• Specific supplier names, supplier rankings, or supplier links.
• Step-by-step procurement workflows or buyer's checklists.
• Reconstitution, dosing, administration or self-experimentation guidance.
• Advice on importing, shipping or routing materials past customs.
• Any content that treats institutional research-grade procurement as a personal-use pathway.

Why we frame this so narrowly

A page on this topic that listed suppliers, ranked them, or implied that institutional research-grade procurement was an alternative route to personal use would not be a research-governance resource — it would be a sourcing guide. We do not write sourcing guides. See why we do not provide dosing or sourcing advice for the editorial position.

Where to go for actual institutional guidance

• Your institution's research office, biosafety officer and ethics committee.
• The MHRA for clinical trials of investigational medicinal products.
• The Home Office for animal-research licensing where ASPA 1986 applies.
• The Health and Safety Executive for hazardous-materials considerations.
• Recognised laboratory analytical standards bodies (BP, USP, EP) for purity and identity standards.